6
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Mild SARS-COV-2 infections in children might be based on evolutionary biology and linked with host reactive oxidative stress (ROS) and antioxidant capabilities

      review-article
      New Microbes and New Infections
      Published by Elsevier Ltd.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection leads to significant morbidity and mortality in elderly. Children typically have mild illness with rare mortalities. Age and comorbid medical conditions are the most important determinant of the infection outcome. Currently there is no clear explanation for difference in disease severity and outcome in different age groups . Based on evolutionary biology and translational research this review suggests that high antioxidant capacity of children leading to a balanced redox state is the key factor for mild SARS-COV-2 infections in this age group. On the other hand, elderly with low antioxidant capacity and ACE2 expression is prone to severe infections by redox sensitive immune modulation.

          Highlights

          • Mild SARS-COV-2 (COVID19) infections in children might be linked with evolutionary biology.

          • Similarity of tissue metabolism between children and bats is likely to be influential in mild SARS-COV-2 (COVID19) infections in children.

          • Severity of SARS-COV-2 (COVID19) infections might be based on host reactive oxidative stress (ROS) and antioxidant capacity.

          • Antioxidants can be considered as first the line agents in prevention and treatment of severe SARS-COV-2 (COVID19) infections until further data about their role in this infection is available.

          Related collections

          Author and article information

          Contributors
          Journal
          New Microbes New Infect
          New Microbes New Infect
          New Microbes and New Infections
          Published by Elsevier Ltd.
          2052-2975
          24 June 2020
          24 June 2020
          : 100723
          Affiliations
          [1]Division of Pediatric Critical Care Medicine, Department of Pediatrics at University of California San Francisco Fresno. 155 N. Fresno Street, Suite 219, Fresno, CA, 93701, Tel: personal +1-617-771-7311, office +1-559-499-6556 Fax: +1-559-499-6561
          Article
          S2052-2975(20)30075-5 100723
          10.1016/j.nmni.2020.100723
          7313508
          32670592
          bba22bf4-1cc3-4447-b31c-a8243caf5fd9
          © 2020 Published by Elsevier Ltd.

          Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

          History
          : 26 April 2020
          : 12 June 2020
          : 22 June 2020
          Categories
          Article

          Comments

          Comment on this article